Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents
Authors:
- Min-Jung KimMKMin-Jung Kim
- Ho-Jeong KwonHKHo-Jeong Kwon
Open Access
- 31 January 2003
- journal article
- review article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 36 (1) , 110-119
Abstract
Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents Anti-cancer agents;Carcinogenesis;Gene expression;Histone deacetylase;Histone deacetylase inhibitors; The acetylation state of histone is reversibly regulated by histone acetyltransferase (HAT) and deacetylase (HDAC). An imbalance of this reaction leads to an aberrant behavior of the cells in morphology, cell cycle, differentiation, and carcinogenesis. Recently, these key enzymes in the gene expression were cloned. They revealed a broad use of this modification, not only in histone, but also other proteins that involved transcription, nuclear transport, and cytoskeleton. These results suggest that HAT/HDAC takes charge of multiple-functions in the cell, not just the gene expression. HDAC is especially known to play an important role in carcinogenesis. The enzyme has been considered a target molecule for cancer therapy. The inhibition of HDAC activity by a specific inhibitor induces growth arrest, differentiation, and apoptosis of transformed or several cancer cells. Some of these inhibitors are in a clinical trial at phase I or phase II. The discovery and development of specific HDAC inhibitors are helpful for cancer therapy, and decipher the molecular mode of action for HDAC.Keywords
This publication has 66 references indexed in Scilit:
- Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signalingOncogene, 2002
- Genomewide studies of histone deacetylase function in yeastProceedings of the National Academy of Sciences, 2000
- NuRD and SIN3Trends in Genetics, 2000
- Histone deacetylases, transcriptional control, and cancerJournal of Cellular Physiology, 2000
- Acetylation of importin-α nuclear import factors by CBP/p300Current Biology, 2000
- Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an AcetylaseCell, 1999
- The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repressionNucleic Acids Research, 1998
- Covalent modifications of histones: expression from chromatin templatesCurrent Opinion in Genetics & Development, 1998
- Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repressionNature, 1997
- The CBP co-activator is a histone acetyltransferaseNature, 1996